Byol Combi 2,5 mg/2,5 mg tvrde kapsule
| Name | Byol Combi 2,5 mg/2,5 mg tvrde kapsule |
|---|---|
| Marketing Authorisation Number | HR-H-459290443 |
| Active Substance | ramipril bisoprololfumarat |
| Composition | svaka tvrda kapsula sadrži 2,5 mg ramiprila i 2,5 mg bisoprololfumarata |
| Pharmaceutical Form | Kapsula, tvrda |
| Manufacturer | Adamed Pharma S.A., Pabianice, Poljska Lek Pharmaceuticals d.d., Ljubljana, Slovenija |
| Marketing Authorisation Holder | Sandoz d.o.o., Maksimirska 120, Zagreb, Hrvatska |
| Marketing Authorisation Date | 11.05.2022 |
| MA Period of Validity | 11.05.2027 |
| Classification Number | UP/I-530-09/20-01/297 |
| Registration Number | 381-12-01/154-22-02 |
| Prescription | na recept |
| Type of prescription | ponovljivi recept |
| Distribution | u ljekarni |
| Advertising to general public | zabranjeno |
| ATC Code | C09BX05 |
| Medicinal product marketed in the Croatia | Da |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
